posted on 2017-05-10, 14:50authored byVišnja Popović, Jan L. Goeman, Nadia Bougarne, Sven Eyckerman, Arne Heyerick, Karolien De Bosscher, Johan Van der Eycken
Species of the genus Laserpitium have been used
traditionally to treat inflammation and infection. From the herb of Laserpitium zernyi, six new compounds were isolated and
their structures elucidated (using IR, NMR, HRMS data) as derivatives
of 8-daucene-2,4,10-triol (1, 2, and 4), 7-daucene-2,4,10-triol (3), a lapiferin derivative
featuring a C-2 ester moiety (5), and a daucane featuring
an exomethylene group at C-8 (6). Also isolated were
the rare daucanes vaginatin (7) and laserpitin (8). In a search for selective glucocorticoid receptor (GR)
modulators, the compounds were tested for their capacity to inhibit
NF-κB and AP-1 pro-inflammatory factors and for a potential
competitive effect on a dexamethasone (Dex)-induced GR-driven glucocorticoid
response element (GRE) reporter gene. The new 2β-angeloyloxy-10α-acetoxy-8-daucene-2,4,10-triol
(2) significantly inhibited transactivation of both NF-κB
and AP-1, while vaginatin (7) was the most active of
the compounds tested in blocking AP-1. Both compounds competitively
repressed Dex-induced GRE-driven promoter activities, indicative of
a potential role for GR. In addition, a decreased potential to inhibit
NF-κB was apparent in GR knockout A549 cells. In line with the
transcriptional assays, compounds 2 and 7 also significantly lowered CCL-2 chemokine production, albeit to
a lesser extent than Dex. The results suggest that daucanes may be
interesting candidates in the search for compounds with GR-modulating
activities.